Holen Sie sich die Stockscreener-App
12.04
3.20%
-0.145
Schlusskurs vom Vortag:
$12.18
Offen:
$12.22
24-Stunden-Volumen:
4,795
Relative Volume:
0.02
Marktkapitalisierung:
$403.98M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.0989
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
-6.32%
1M Leistung:
-11.49%
6M Leistung:
-14.81%
1J Leistung:
+6.60%
1-Tages-Spanne:
$11.85
$12.26
1-Wochen-Bereich:
$11.21
$12.78
52-Wochen-Spanne:
$9.70
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Firmenname
Benitec Biopharma Inc
Sektor
Branche
Telefon
(510) 780-0819
Adresse
3940 TRUST WAY, HAYWARD, CA
Vergleichen Sie BNTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
11.93 | 412.44M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.19 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.19 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Eingeleitet | TD Cowen | Buy |
| 2024-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-09-12 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Piper Sandler | Overweight |
| 2020-10-05 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-04-20 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-02-26 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-31 | Bestätigt | Maxim Group | Buy |
| 2015-09-16 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten
Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - ulpravda.ru
Why Benitec Biopharma Inc. stock could be next big winnerStraddle and Strangle Trades & Superior Capital Trading Plans - bollywoodhelpline.com
Published on: 2026-01-09 06:38:29 - ulpravda.ru
Is Benitec Biopharma Inc. stock a buy on dipsGap Up & Verified Swing Trading Watchlist - ulpravda.ru
Benitec Biopharma Inc. (BNTC) Investor Outlook: Exploring a 105.93% Potential Upside in Genetic Medicine - DirectorsTalk Interviews
Can Benitec Biopharma Inc. stock double in next 5 yearsPortfolio Risk Assessment & Free Phenomenal Capital Appreciation - ulpravda.ru
Suvretta Capital Management, LLC Acquires Additional Shares in B - GuruFocus
Discipline and Rules-Based Execution in BNTC Response - Stock Traders Daily
Tahmar Enterprises Limited (516032) Announces Strategic ShiftReal-Time Stock Alerts & Free Stock Trading Workshops - earlytimes.in
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 16,836 Shares - Defense World
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Buys 77,387 Shares of Stock - Defense World
Suvretta Capital Management, L Purchases 77,387 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m By Investing.com - Investing.com Nigeria
Suvretta Capital buys Benitec Biopharma (BNTC) shares for $1.9m - Investing.com India
Does Benitec Biopharma (BNTC) Have the Potential to Rally 83.87% as Wall Street Analysts Expect? - Eastern Progress
Wall Street analysts predict an 87.48% upside in Benitec Biopharma (BNTC): Here's what you should know - MSN
(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Purchases 10,215 Shares of Stock - Defense World
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 By Investing.com - Investing.com Australia
Benitec Biopharma (NASDAQ:BNTC) Director Suvretta Capital Management, L Acquires 16,384 Shares - MarketBeat
Suvretta Capital Management, L Acquires 10,215 Shares of Benitec Biopharma (NASDAQ:BNTC) Stock - MarketBeat
Insider Buying: Benitec Biopharma (NASDAQ:BNTC) Director Acquires 19,542 Shares of Stock - MarketBeat
Benitec Biopharma: Suvretta capital buys BNTC shares worth $538,972 - Investing.com
Why Benitec Biopharma Inc. stock attracts global investorsQuarterly Market Review & Community Verified Trade Alerts - Улправда
Benitec Biopharma Earnings Notes - Trefis
Can Benitec Biopharma Inc. stock outperform in 2025 bull market - Улправда
Benitec Biopharma Concludes 2025 Annual Stockholders Meeting - MSN
Will Benitec Biopharma Inc. stock attract more institutional investorsWeekly Investment Report & Smart Investment Allocation Insights - DonanımHaber
Entry Recap: Can Benitec Biopharma Inc. stock outperform in 2025 bull marketLong Setup & Daily Chart Pattern Signals - Улправда
Technical Charts Suggest Momentum Shift in Suraj Estate Developers LimitedPrice Action Analysis & Small Investment Growth Tips - earlytimes.in
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Benitec Biopharma Limited (NASDAQ:BNTC) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Will Benitec Biopharma Inc stock pay special dividendsJuly 2025 Gainers & AI Driven Stock Movement Reports - moha.gov.vn
Janus Henderson Group PLC's Strategic Acquisition in Benitec Bio - GuruFocus
Aug Setups: Is Benitec Biopharma Inc stock resilient to inflationQuarterly Portfolio Summary & High Return Stock Watch Alerts - moha.gov.vn
Benitec Biopharma prices $100M stock offering - MSN
Wall Street Analysts Predict an 87.48% Upside in Benitec Biopharma (BNTC): Here's What You Should Know - Yahoo Finance
Down 25.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Benitec Biopharma (BNTC) - Yahoo Finance
Benitec Biopharma shareholders approve all proposals at annual meeting By Investing.com - Investing.com Australia
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '25 |
Buy |
12.85 |
50,000 |
642,500 |
9,620,075 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 26 '25 |
Buy |
13.10 |
16,836 |
220,552 |
9,634,395 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 22 '25 |
Buy |
12.08 |
19,542 |
236,067 |
9,577,475 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 19 '25 |
Buy |
11.48 |
16,384 |
188,088 |
9,560,825 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 18 '25 |
Buy |
11.24 |
10,215 |
114,817 |
9,546,875 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 07 '25 |
Buy |
13.50 |
1,481,481 |
19,999,994 |
9,538,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 31 '25 |
Buy |
12.83 |
16,497 |
211,736 |
8,807,805 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):